Advertisement
Sunday, Dec 05, 2021
Outlook.com
Outlook.com

ICMR To Pair With Oxford For Clinical Trial Of COVID-19 Therapy Evaluation

The trial, 'India-UK RECOVERY (Randomised Evaluation of COVID-19 therapy)', will be a multi-centre, adaptive platform trial on COVID patients, ICMR said on Friday.

ICMR To Pair With Oxford  For Clinical Trial Of COVID-19 Therapy Evaluation
Representational Image | PTI
ICMR To Pair With Oxford For Clinical Trial Of COVID-19 Therapy Evaluation
outlookindia.com
2021-07-10T11:42:22+05:30

The Indian Council of Medical Research (ICMR) has proposed a collaborative endeavour  of conducting a clinical trial for 'randomised evaluation of COVID-19 therapy' with the University of Oxford. ICMR  expects the hospitals to come up with expression of intent .

According to the officials, the trial, 'India-UK RECOVERY (Randomised Evaluation of COVID-19 therapy)', is desihned to be a multi-centre, adaptive platform trial on Covid patients, 

"ICMR, Delhi, along with the University of Oxford is proposing to conduct a multi-centre, adaptive platform trial on COVID-19 patients, titled 'India-UK RECOVERY (Randomised Evaluation of COVID-19 therapy)," it said.

"An expression of intent is sought from institutions/hospitals with the facilities and capacity available to participate in the clinical trial which will enroll participants admitted in their hospitals."

According to the ICMR, the intervention arm of the trial will include baricitinib and the control arm will receive local standard of care. The trial will be initiated only after obtaining requisite regulatory and ethics approvals.

"Institutions which are interested to collaborate with ICMR on undertaking this trial may express their interest by providing the details," it said.

Informed consent has to be obtained from each patient before enrolment into the study.

The protocol of the study describes a randomised trial among patients hospitalised for COVID-19. All eligible patients are randomly allocated between several treatment arms, each to be given in addition to the usual standard of care in the participating hospital.

At the Indian sites, all participants aged 18 years or above will be allocated to baricitinib vs. no additional treatment. The interim trial results will be monitored by an independent Data Monitoring Committee. 

(With PTI Inputs)

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Kashmir: Tosa Maidan Blast Victims Still Await Compensation

Kashmir: Tosa Maidan Blast Victims Still Await Compensation

While the Army and Airforce vacated the Tosa Maidan meadow as a firing range back in 2014, the victims of the deadly explosions are yet to receive their compensation.

Church In India Cosying Up To BJP To Protect Its Interests

Church In India Cosying Up To BJP To Protect Its Interests

What has led to this change of heart over the past few years for the Church, long seen to be anathemic to the Sangh Parivar?

2nd Test: Ravi Ashwin's 3/27 Puts India On Top At Day 3 Stumps

2nd Test: Ravi Ashwin's 3/27 Puts India On Top At Day 3 Stumps

At the end of Day 3, New Zealand are struggling at 140/5 with 400 more runs to win the second Test in Mumbai. Daryl Mitchell scored a fighting 60. Catch the IND vs NZ highlights here.

World Soil Day 2021: Why Is Soil Conservation Important?

World Soil Day 2021: Why Is Soil Conservation Important?

World Soil Day was first celebrated on December 5th 2014, 7 years ago. This year's theme is, 'Halt soil salinization, boost soil productivity'.

Advertisement